Related references
Note: Only part of the references are listed.Skeletal muscle susceptibility to clofibrate induction of lesions in rats
Miyoko Okada et al.
TOXICOLOGIC PATHOLOGY (2007)
Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation
S Matzno et al.
LIFE SCIENCES (2006)
Statins and PPARα agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment
TE Johnson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-α (PPARα)-regulated genes and is ameliorated by PPARα activation
AA Nanji et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I
B Brunmair et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise
H Pilegaard et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle
AP Russell et al.
DIABETES (2003)
A metabolic switching hypothesis for the first step in the hypolipidemic effects of fibrates
K Motojima
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Intramuscular triacylglycerol utilization in human skeletal muscle during exercise: is there a controversy?
MJ Watt et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Skeletal muscle heterogeneity in fasting-induced upregulation of genes encoding UCP2, UCP3, PPARγ and key enzymes of lipid oxidation
S Samec et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2002)
Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor α (PPARα)
MJ Holness et al.
BIOCHEMICAL JOURNAL (2002)
Myopathy and rhabdomyolysis with lipid-lowering drugs
C Hodel
TOXICOLOGY LETTERS (2002)
A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle
A Minnich et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Share Paper
